Skip to content

Clinical trials

Phase 2 Sarcoma trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sarcoma Phase: Phase 2 Status: Unknown status Clear all

66 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20022
20031
20043
20051
20061
20072
20084
20092
20101
20113
20121
20131
20141
20153
20162
20175
20182
20198
20207
20214
20224
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status66

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Herbert Irving Comprehensive Cancer Center5
Fudan University4
Sun Yat-sen University4
Maria Sklodowska-Curie National Research Institute of Oncology3
Tianjin Medical University Cancer Institute and Hospital3
Assaf-Harofeh Medical Center2
Grupo Espanol de Investigacion en Sarcomas2
Japan Rhabdomyosarcoma Study Group2
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.2
AC Camargo Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sarcoma66
Histiocytoma, Malignant Fibrous6
Liposarcoma6
Liposarcoma, Myxoid6
Leiomyosarcoma5
Osteosarcoma5
Fibrosarcoma4
Neurofibrosarcoma4
Ovarian Neoplasms4
Recurrence4

Trials

Showing 1 to 25 of 66. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.